UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 162 filers reported holding UNIQURE NV in Q3 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,838,000 | -67.6% | 239,978 | -62.9% | 0.00% | -71.4% |
| Q2 2020 | $27,281,000 | -9.2% | 646,480 | +2.1% | 0.01% | -30.0% |
| Q1 2020 | $30,038,000 | -31.3% | 633,044 | +3.7% | 0.02% | -13.0% |
| Q4 2019 | $43,753,000 | +104.5% | 610,570 | +12.3% | 0.02% | +91.7% |
| Q3 2019 | $21,394,000 | -58.8% | 543,550 | -18.2% | 0.01% | -57.1% |
| Q2 2019 | $51,907,000 | +56.5% | 664,200 | +19.5% | 0.03% | +55.6% |
| Q1 2019 | $33,165,000 | +445.7% | 556,000 | +163.6% | 0.02% | +350.0% |
| Q4 2018 | $6,078,000 | -46.3% | 210,900 | -32.3% | 0.00% | -33.3% |
| Q3 2018 | $11,328,000 | +23.1% | 311,300 | +27.8% | 0.01% | +20.0% |
| Q2 2018 | $9,204,000 | – | 243,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |